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Abstract
SARS coronavirus (SCoV) nonstructural protein (nsp) 1, a potent inhibitor of host gene expression, possesses a unique mode
of action: it binds to 40S ribosomes to inactivate their translation functions and induces host mRNA degradation. Our
previous study demonstrated that nsp1 induces RNA modification near the 59-end of a reporter mRNA having a short 59
untranslated region and RNA cleavage in the encephalomyocarditis virus internal ribosome entry site (IRES) region of a
dicistronic RNA template, but not in those IRES elements from hepatitis C or cricket paralysis viruses. By using primarily cell-
free, in vitro translation systems, the present study revealed that the nsp1 induced endonucleolytic RNA cleavage mainly
near the 59 untranslated region of capped mRNA templates. Experiments using dicistronic mRNAs carrying different IRESes
showed that nsp1 induced endonucleolytic RNA cleavage within the ribosome loading region of type I and type II
picornavirus IRES elements, but not that of classical swine fever virus IRES, which is characterized as a hepatitis C virus-like
IRES. The nsp1-induced RNA cleavage of template mRNAs exhibited no apparent preference for a specific nucleotide
sequence at the RNA cleavage sites. Remarkably, SCoV mRNAs, which have a 59 cap structure and 39 poly A tail like those of
typical host mRNAs, were not susceptible to nsp1-mediated RNA cleavage and importantly, the presence of the 59-end
leader sequence protected the SCoV mRNAs from nsp1-induced endonucleolytic RNA cleavage. The escape of viral mRNAs
from nsp1-induced RNA cleavage may be an important strategy by which the virus circumvents the action of nsp1 leading
to the efficient accumulation of viral mRNAs and viral proteins during infection.
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Introduction
Severe acute respiratory syndrome (SARS) coronavirus (SCoV)
is the causative agent of SARS, which was first recognized in
southern China in 2002 and spread to different areas of the world
in a 2002-2003 epidemic [1-3]. It is believed that the bat-derived
SCoV-like CoV [4,5] underwent several mutations enabling the
virus to cross the species barrier and replicate efficiently in humans
[6]. Although it is uncertain whether SCoV-like CoV will re-
emerge in the human community and initiate another SARS
epidemic, the previous SARS outbreak made it apparent that
CoVs, which usually cause only mild or moderate self-limiting
symptoms in healthy humans, can cause a severe epidemic disease
in our communities.
SCoV, which belongs to the betaCoV genus among the alpha,
beta and gammaCoV genera in the family Coronaviridae,i sa n
enveloped RNA virus carrying a long (,30 kb), single-stranded,
positive-sense genomic RNA. The 59-proximal ,22 kb-long gene
1 region of SCoV genomic RNA has two partially overlapping
open reading frames (ORFs) 1a and 1b (Figure 1). Immediately
after infection, the genomic RNA is translated to produce two
large polyproteins; one is from ORF1a and the other from ORF1a
and 1b via a ribosomal frame-shift mechanism [6,7]. These two
polyproteins are processed by two viral proteinases to generate 16
mature proteins, nsp1-nsp16 (Figure 1). Most of the gene 1
proteins are involved in viral RNA synthesis [8-16], while some
have other biological functions [17-21]. To carry out viral gene
expression, nine species of virus-specific mRNAs, including
mRNA1, which is the intracellular form of genomic RNA, and
eight species of subgenomic mRNAs, i.e., mRNA 2-mRNA 9, are
produced in infected cells. These viral mRNAs make up a 39-co-
terminal, nested-set structure and accumulate in different
quantities. Located at the 59-end of all of these intracellular viral
mRNAs and genomic RNAs is a ,70 nt-long identical leader
sequence.
SCoV nsp1 protein, which is the most N-terminal product of the
gene 1 polyproteins, suppresses host gene expression in expressed
cells and in infected cells [19,22]. Nsp1 prevents type I interferon
production in infected cells [23], and the expressed nsp1
suppresses the host antiviral signaling pathways [24]. Furthermore,
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gene expression, interferes with the type I interferon system, and is
a virulence factor [25]. These data led us to suggest that SCoV
nsp1 plays important roles in SARS pathogenesis. SCoV nsp1
suppresses host gene expression by using a novel, two-pronged
strategy [19,22]. Nsp1 binds to 40S ribosomes, leading to the
inhibition of host protein synthesis. Ribosome-bound nsp1 further
induces RNA modification of a capped mRNA, rendering it
translationally incompetent [22]. Nsp1 protein promotes host
mRNA degradation both in transiently transfected cells expressing
nsp1 and in infected cells [19,22,23,26]; cellular RNA decay
functions most likely influence the efficient degradation of host
mRNAs that undergo the nsp1-induced modification. The nsp1-
induced RNA modification is template-dependent. Incubation of
nsp1 in rabbit reticulocyte lysate (RRL) with a dicistronic RNA
transcript harboring the encephalomyocarditis virus (EMCV)
internal ribosome entry site (IRES) between two reporter genes
results in RNA cleavage near the 39-region of the EMCV IRES
element, whereas nsp1 does not induce RNA cleavage in the IRES
region of dicistronic RNA transcripts containing either the
hepatitis C virus (HCV) IRES or the cricket paralysis virus (CrPV)
IRES [22]. The molecular basis for the nsp1-mediated selective
endonucleolytic RNA cleavage among these IRESes is unclear.
Incubation of capped and polyadenylated reporter mRNA
encoding the Renilla luciferase (rluc) gene with nsp1 in RRL
and subsequent primer extension analysis of the reporter mRNA
showed that the nsp1 induces several premature primer extension
termination signals near the 59-end of the mRNA [22]. Neither the
nature of the nsp1-induced modification of capped mRNA nor the
mechanism of the RNA modification site selection is known. Also
unknown is the effect of nsp1 on SCoV mRNAs. Similar amounts
of virus-specific mRNAs are detected in SCoV-infected cells and
in cells infected with a SCoV mutant, SCoV-mt, which encodes
the nsp1-mt protein carrying K164A and H165A mutations [23].
This mutated form of nsp1 neither binds to 40S ribosome subunits
[22] nor promotes mRNA degradation [23], which suggests that
SCoV mRNAs may escape from the nsp1-induced mRNA
modification.
The present study was undertaken to clarify the nature of the
nsp1-induced modification in capped mRNAs, explore the basis of
the RNA modification site selection, characterize the template-
dependent properties of the nsp1-induced RNA modification, and
examine the effect(s) of nsp1 on the integrity of SCoV mRNAs
primarily by using cell-free in vitro assays. Our data demonstrate
that endonucleolytic RNA cleavage was the nature of the nsp1-
induced modification of RNA templates, and RNAs carrying
selective groups of IRESes were susceptible to the nsp1-induced
RNA cleavage. The contribution of RNA secondary structures of
template mRNAs for the selection of the RNA cleavage sites is also
Figure 1. Schematic diagram of the SCoV genome. The viral genome consists of a single-stranded, positive-sense RNA of ,29.7 kb in length.
The 59-proximal gene 1 (,22-kb) has two ORFs, ORF1a and 1b, which encodes for large polyproteins, polyprotein 1a and polyprotein 1ab. The
polyproteins are cleaved into 16 mature non-structural proteins (nsp1-nsp16) by viral proteases PL
pro and 3CL
pro. Most of the non-structural proteins
are involved in viral RNA synthesis and some of the identified functions of the non-structural proteins are: ADRP, ADP-ribose-1’’-phosphate
phosphatase [14]; PL
pro, papain-like protease [72]; 3CL
pro, 3C-like protease [73]; Pr, primase [11]; ssRBP, single-stranded RNA-binding protein [74];
RDRP, RNA-dependent RNA polymerase [9]; Hel, helicase [16]; ExoN, 3959 exoribonuclease; N7-MTase, guanine-N7-methyltransferase [69]; NendoU,
poly(U)-specific endoribonuclease [8]; and 29OMT, 29 O-methyltransferase [68]. Major viral structural proteins, including S, M, N and E, and the
accessory proteins, including 3a, 3b, 6, 7a, 7b, 8a, 8b, and 9b, are encoded downstream of the ORF1a/1b.
doi:10.1371/journal.ppat.1002433.g001
Author Summary
Severe acute respiratory syndrome (SARS) coronavirus
(SCoV) is the causative agent of SARS. The nsp1 protein of
SCoV blocks host protein synthesis, including type I
interferon, a general inhibitor of virus replication, in
infected cells. This finding suggests that SCoV nsp1
protein plays a key role in the severe symptoms that
accompany SARS infection. Nsp1 binds to the 40S
ribosome subunit, which is an essential component for
protein synthesis, and inactivates the translation activity of
the ribosome. Furthermore, nsp1 binding to the 40S
ribosome induces the modification of host mRNAs, leading
to the accelerated decay of these RNAs in SCoV-infected
cells. We found that the nature of nsp1-induced RNA
modification was RNA cleavage and that nsp1 did not
recognize specific nucleotides in host mRNAs to induce
this cleavage. Interestingly, nsp1 did not induce RNA
cleavage in SCoV mRNAs. These data indicate that nsp1
induces RNA cleavage of host mRNAs to suppress the
expression of host genes, including those having antiviral
functions; yet viral mRNAs are spared from such cleavage
events, which, most likely, facilitate efficient SCoV protein
synthesis and virus replication in infected cells.
RNA Cleavage Caused by SARS Coronavirus nsp1
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resistant to the nsp1-induced RNA modification, a finding
suggesting that SCoV has developed a strategy to selectively
protect its own mRNAs from nsp1-induced RNA modifications to
ensure efficient viral gene expression during infection.
Results
Susceptibilities of dicistronic mRNAs carrying different
IRESes to nsp1-induced RNA cleavage
SCoV nsp1 induces endonucleolytic RNA cleavage near the 39-
region of the EMCV IRES of dicistronic RNA transcripts, Ren-
EMCV-FF, in which expression of the upstream rluc ORF is
mediated by cap-dependent translation and the translation of
downstream firefly luciferase (fluc) ORF is driven by the EMCV
IRES in both RRL [22] and cultured cells [27]. In contrast, SCoV
nsp1 does not induce RNA cleavage in similar dicistronic RNA
transcripts carrying the HCV IRES or the CrPV IRES between
rluc and fluc genes in RRL [22]. EMCV, HCV and CrPV belong
to the picornavirus family, flavivirus family and dicistrovirus
family, respectively. Although currently divided into four distinct
categories [28], picornavirus IRES elements were originally
grouped into type I and type II IRESes based on their primary
sequence and secondary structure similarities [29]. IRES elements
within the same IRES group display a high homology in RNA
secondary structures, but only modest similarity in their primary
sequences, while IRESes from different groups have distinct RNA
secondary structures. Picornavirus type I IRESes include IRESes
derived from poliovirus, coxsackie B virus (CVB) and human
rhinovirus (HRV), while picornavirus type II IRESes include those
derived from EMCV and Theiler’s murine encephalomyelitis
(TMEV). Because HCV, CrPV and picornavirus type I and type II
IRESes are distinct in terms of their primary sequences, secondary
structures and requirements for translation initiation factors (for
review refer to [30-32]), testing the susceptibilities of these IRESes
to nsp1-induced endonucleolytic RNA cleavage would provide a
clue towards understanding the role of RNA secondary structures
and host translation initiation factors in the nsp1-induced RNA
cleavage.
To determine the molecular basis for the nsp1-induced,
template-dependent endonucleolytic RNA cleavage, we tested
whether nsp1 induced RNA cleavage in the IRES region of a
series of dicistronic RNA transcripts, each containing an IRES
derived from different picornaviruses, including TMEV (Ren-
TMEV-FF), poliovirus (Ren-PV-FF), CVB (Ren-CVB-FF), and
HRV 2 (Ren-HRV2-FF) or a flavivirus, classical swine fever virus
(CSFV) (Ren-CSFV-FF); the latter IRES has an HCV-like IRES
structure. In all transcripts, expression of the upstream rluc ORF
was mediated by cap-dependent translation and the translation of
downstream fluc ORF driven by the IRES. The Ren-TMEV-FF
or Ren-CSFV-FF transcripts were incubated in RRL with a
recombinant nsp1 protein, which was initially expressed as
glutathione S-transferase (GST)-nsp1 fusion protein in E. coli.
The GST tag was subsequently eliminated [19]. For analysis of
Ren-PV-FF, Ren-CVB-FF and Ren-HRV2-FF transcripts, RRL
containing 20% (vol/vol) HeLa S10 extract [33] (RRL+HeLa) was
used; translation activities of these picornavirus-derived IRESes
require host factors that are missing or exist in low abundance in
RRL [34-36]. Thus, RRL+HeLa is used for translation mediated
by these IRESes [37]. As controls, the RNA was left untreated or
incubated with a non-specific control protein,GST or a mutated
form of nsp1, nsp1-mt with K164A and H165A mutations [23].
Nsp1-mt does not bind to 40S ribosomes and lacks the
translational suppression and template RNA modification activi-
ties [19,23]. After incubation, RNAs were extracted and subjected
to Northern blot analysis by using an rluc probe hybridizing to the
rluc ORF and a fluc probe hybridizing to the fluc ORF (Figure 2
and Figure S1). To estimate the RNA cleavage sites, we included
three RNA size markers for each template RNA; they were an
untreated template (full length), RNA 1 containing the region from
the 59-end to the 39-end of the inter-cistronic region of the
template, and RNA 2 containing the region from the 59-end to the
end of the rluc ORF of the template (Figure 2A). As expected,
incubation of all RNA transcripts with GST or nsp1-mt did not
induce RNA cleavage (marked as GST and nsp1 mt in Figure 2
and Figure S1). Incubation of Ren-TMEV-FF with nsp1 resulted
in reduction of full-length transcript abundance and generation of
two major RNA fragments (Figure 2B). The size of the 59-
fragment, which was detected by the rluc probe, indicated that
nsp1 induced an endonucleolytic cleavage near the 39-end of
TMEV IRES. All RNA transcripts carrying picornavirus type I
IRES, including Ren-PV-FF, Ren-CVB-FF and Ren-HRV2-FF,
underwent the nsp1-induced RNA cleavage (Figure 2C, Figures
S1B and S1C). Ren-PV-FF preparations contained an unexpected
RNA band, which was detected by the rluc probe and was slightly
smaller than the RNA 1 marker (denoted by the asterisk in
Figure 2C), leading us to suggest that this RNA was generated by
premature transcriptional termination near the 39 end of the
poliovirus IRES. The 59 fragment of dicistronic transcripts
carrying picornavirus type II IRES and the RNA 1 markers
showed a similar migration in the gel (Figure 2B) [22], whereas the
corresponding RNA fragment of dicistronic transcripts carrying a
picornavirus type I IRES migrated slightly faster than did the
RNA 1 markers in the gels; the size difference between the 59
fragment of Ren-HRV2-FF and the RNA 1 maker was less
prominent than those between the 59 fragment of Ren-PV-FF or
Ren-CVB-FF and their RNA 1 makers (Figure 2 and Figures S1B
and S1C). In contrast to dicistronic transcripts carrying picorna-
virus type I IRES or type II IRES, nsp1 did not induce RNA
cleavage in Ren-CSFV-FF (Figure 2D).
We previously reported that co-transfection of a plasmid
encoding nsp1 and one that encoded dicistronic RNA transcripts
carrying the EMCV IRES resulted in RNA cleavage of the
expressed dicistronic RNA transcripts, demonstrating that ex-
pressed nsp1 exerts RNA cleavage in cultured cells [27]. The
finding of RNA cleavage following co-expression in cultured cells
of nsp1, but not nsp1-mt or chloramphenicol acetyltransferase
(CAT), with dicistronic RNA transcripts carrying the TMEV
IRES or poliovirus IRES, but not those carrying the HCV IRES
or CSFV IRES, (Figure S2) demonstrated that expressed nsp1
exerted template-dependent endonucleolytic RNA cleavage. In
addition, nsp1 expression reduced the abundances of the full-
length RNAs of all of the expressed RNA transcripts. Because the
nsp1 induces modification at the 59 region of the capped RNA
transcripts in RRL [22], we suspect that expressed RNAs most
likely underwent nsp1-induced modification near the 59 end and
were degraded by host mRNA decay functions, resulting in the
reduction of the abundance of the expressed RNA transcripts in
nsp1-expressing cells. In summary, nsp1 induced endonucleolytic
RNA cleavage in RNA transcripts carrying the IRESes of
picornaviruses, but not in those carrying CSFV IRES, both in
vitro and in vivo.
Identification of the endonucleolytic RNA cleavage sites
in Ren-EMCV-FF and Ren-PV-FF
We next determined the nsp1-induced RNA cleavage sites in
Ren-EMCV-FF and Ren-PV-FF RNA. We took advantage of the
fact that the RNA structure as well as the structural and functional
RNA Cleavage Caused by SARS Coronavirus nsp1
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characterized [38,39]. Ren-EMCV-FF that had been incubated
with GST, nsp1 or nsp1-mt in RRL was subjected to primer
extension analysis using the 59-end labeled primer that binds at a
site ,100 nt downstream of the fluc gene initiation codon. Three
strong (sites 3, 7 and 11) and several minor primer extension
termination signals were detected in the sample that was incubated
with nsp1, but not with GST or nsp1-mt (Figure 3A). Site 3 was
located 3-nt downstream of the translation initiation AUG (AUG-
834) of the EMCV IRES (underlined AUG in Figure 3C), while
sites 7 and 11 were located within the 59 region of the fluc ORF.
Two minor primer extension termination sites 1 and 2 existed
upstream of AUG-834 and other minor sites were detected
between AUG-834 and site 11. Previous studies reported the
possibility that the 43S pre-initiation complex, which is made up
with 40S ribosome, eIF1, eIF1A, ternary complex (eIF2, Met-
tRNA, and GTP), and eIF3, loads onto the EMCV IRES at or
near the AUG-834 [40,41]. Hence, our data may indicate that
nsp1 induced several endonucleolytic RNA cleavages at or in the
proximity of the ribosome loading site of the EMCV IRES of Ren-
EMCV-FF.
Northern blot analysis indicated that the nsp1 induced the
RNA cleavage roughly 100-200 nt upstream of the initiation
codon of the downstream fluc ORF of Ren-PV-FF (Figure 2C);
hence, for primer extension analysis of Ren-PV-FF we used a
primer that binds at a site 6 nt downstream of the translation
initiation codon of the fluc ORF. Primer extension analysis of
Ren-PV-FF that had been incubated with nsp1, but not with
GST or nsp1-mt, in RRL+HeLa revealed three major extension
termination signals, namely sites 1, 2 and 8, near an AUG (AUG-
586), which corresponds to the AUG at 586 nt of the poliovirus
genome, located within the poliovirus IRES domain VI
(Figures 3B and 3D). All three major sites 1, 2 and 8, and a
minor site 7 were located in close proximity within the computer-
predicted secondary structure of poliovirus IRES domain VI
(Figure 3D). Other minor primer extension termination sites were
located downstream of AUG-586, which is considered to be a
part of ribosome binding site within poliovirus IRES. It should be
noted that AUG-586 is not used for viral translation initiation
[42]; viral translation initiates from another AUG triplet (AUG-
743) located ,150 nt downstream of this silent AUG-586 by
ribosome shunting or scanning mechanisms [42-44]. In the Ren-
PV-FF transcripts, AUG-743 served as the translation initiation
codon for the fluc gene. Judging from the migration of the 59
RNA cleavage product of the Ren-PV-FF relative to marker
RNA 1, which is an RNA fragment corresponding to the 59-end
of Ren-PV-FF to 30-nt downstream of AUG-743 (Figure 2C), the
size of the 59 RNA fragment of Ren-PV-FF and the major RNA
Figure 2. Susceptibilities of IRES-containing dicistronic RNAs to nsp1-mediated RNA cleavage. (A) Schematic diagram of the structures
of full length dicistronic RNA transcripts (Full length), RNA 1 containing the 59 rluc gene and intercistronic IRES sequence and RNA 2 containing only
the 59 rluc gene. (B) Ren-TMEV-FF was incubated with GST, nsp1 or nsp1-mt or without any protein (mock) in RRL at 30
oC for 10 min. RNA samples
were extracted and analyzed by Northern blot analysis using the 59 rluc probe (left panel) and 39 fluc probe (right panel). Marker is a mixture of in
vitro-transcribed, full-length RNA transcripts, RNA 1 and RNA 2. (C) Ren-PV-FF was examined as in (B), except RNA was incubated in RRL+HeLa. RNA 2,
full length dicistronic RNA transcripts and RNA 1 were separately applied to the gel and shown in three marker lanes. An asterisk represents a
truncated RNA product, which was probably generated by premature transcription termination around the IRES region of full-length RNA and RNA 1.
(D) Ren-CSFV-FF was examined as described in (B).
doi:10.1371/journal.ppat.1002433.g002
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PLoS Pathogens | www.plospathogens.org 4 December 2011 | Volume 7 | Issue 12 | e1002433Figure 3. Primer extension analysis of Ren-EMCV-FF and Ren-PV-FF after incubation with GST, nsp1 or nsp1-mt. (A, B) In vitro-
synthesized Ren-EMCV-FF (A) and Ren-PV-FF (B) were incubated with GST, nsp1 or nsp1-mt in RRL (A) and RRL+HeLa (B), respectively. The RNAs were
extracted and subjected to primer extension analysis by using the 59-end
32P labeled primer that binds at ,100 nt downstream of the fluc translation
initiation codon for Ren-EMCV-FF (A) or a labeled primer that binds 6 nt downstream of the fluc initiation codon region for Ren-PV-FF (B). Primer
extension products and DNA sequence ladders, which were generated from the plasmid used for RNA synthesis and the primer used for primer
extension analysis, were resolved on 8% polyacrylamide/7M Urea DNA sequencing gels. Premature primer extension termination signals are indicated
RNA Cleavage Caused by SARS Coronavirus nsp1
PLoS Pathogens | www.plospathogens.org 5 December 2011 | Volume 7 | Issue 12 | e1002433cleavage sites 1, 2 and 8 in Ren-PV-FF were in good agreement.
We did not detect major primer extension termination products
near AUG-743 following the use of another primer that binds
,100 nt downstream of the AUG-743 (data not shown). These
data strongly suggested that nsp1 induced RNA cleavage at or
near the 40S ribosome loading site within poliovirus IRES of
Ren-PV-FF.
Characterization of the SCoV nsp1-induced RNA
modification of capped non-viral mRNAs
Our previous studies used rluc RNA, which is a capped and
polyadenylated mRNA encoding the rluc gene, as a model mRNA
template for characterizing the nsp1-induced capped mRNA
modification [22]. Incubation of rluc RNA with nsp1 in RRL
generated several premature primer extension termination prod-
ucts indicative of cleavage near the 59-end of rluc RNA, and the
modified rluc RNA became translationally inactive [22]. The
nature of the nsp1-induced modification, which causes primer
extension terminations, in the rluc RNA is unknown. The rluc
RNA has a short, 59 untranslated region (UTR) of only 11 nt,
which is atypical for most host mRNAs which have 59 UTRs
ranging from 20-100 nt in length [45]. Rabbit globin mRNA
having a 53 nt-long 59 UTR and b-actin mRNA carrying an
84 nt-long 59 UTR are two of the host mRNAs widely utilized in
molecular biology studies [46-50]. Thus, we used two in vitro-
synthesized capped and polyadenylated mRNAs encoding the rluc
gene which carried the 59 UTR of human b-actin mRNA or that
of rabbit b-globin mRNA to characterize nsp1-mediated RNA
modification of capped, monocistronic mRNAs. Incubation of
ALA mRNA (containing the b-actin 59 UTR) or GLA mRNA
(containing the rabbit b-globin 59 UTR) with nsp1, but not GST
or nsp1-mt, in RRL resulted in the efficient suppression of rluc
protein expression (Figures 4A and 5A). Primer extension analysis
of ALA mRNA, which was extracted from RRL after incubation
with nsp1, but not with GST or nsp1-mt, showed two main
premature primer extension termination products at nucleotides
29 (site 3) and 39 (site 4) (Figure 4B, indicated by asterisks) and
several minor premature primer extension termination signals
(Figure 4B, arrows). Incubation of GLA mRNA with nsp1, but not
GST or nsp1-mt, resulted in a major premature primer extension
termination product at nucleotide 17 (site 4) and several additional
minor premature primer-extension termination sites (Figure 5B,
arrows). The computer-assisted modeling of secondary structure
[51] of the 59 UTR of ALA mRNA showed a proximal location of
sites 3 and 4 in a stem region of a stem-loop structure (Figure 4D).
Likewise, a major RNA modification site 4 and a minor RNA
modification site 5 of GLA mRNA were detected in close
proximity to one another within a stem region of a predicted
stem-loop structure (Figure 5D).
To confirm that nsp1 also induces RNA modification in
naturally occurring host mRNAs, rabbit b-globin mRNA obtained
from RRL was incubated with GST, nsp1 or nsp1-mt in RRL,
and the extracted RNA was subjected to primer extension analysis.
A major premature extension termination site and ,8 minor
products were detected in the sample incubated with nsp1, but not
nsp1-mt or GST (Figure 6). All three RNA modification sites
within the 59 UTRs of b-globin mRNA were also detected at the
corresponding sites of the nsp1-treated GLA mRNA, whereas the
most 59-end minor modification sites 1-3 of GLA mRNA
(Figures 5B and 5C) were barely detected in b-globin mRNA.
The amount of the full-length primer extension product of the
nsp1-treated b-globin mRNA was very low (Figure 6), which
indicated that there was efficient nsp1-induced RNA modification
in the naturally occurring b-globin mRNA.
To further clarify the nature of the nsp1-induced RNA
modification of the capped mRNAs,
32P cap-labeled ALA mRNA,
extracted after incubation with GST, nsp1 or nsp1-mt in RRL,
was subjected to electrophoresis in a 10% polyacrylamide/8M
urea sequencing gel. A major ,29 nt RNA product was detected
in the sample incubated with nsp1, but not with GST or nsp1-mt
(Figure 7), which showed that nsp1 induced an endonucleolytic
RNA cleavage in ALA mRNA. Notably, this endonucleolytic
RNA cleavage product appeared to correspond to a major primer
extension termination site 3 (Figure 4).
Experiments using Ren-EMCV-FF, Ren-PV-FF, GLA
mRNA, b-globin mRNA, or ALA mRNA collectively showed
that the nsp1 induced endonucleolytic RNA cleavages adjacent
to any of the four nucleotides and between different di-
nucleotide pairs, which may imply there is little or no preference
for specific nucleotides at the RNA cleavage site. Computer-
assisted RNA secondary structure analysis implicated a main
RNA cleavage and another RNA cleavage occurring at highly
proximal positions within stem-loop structures in the 59
noncoding region of ALA, b-globin and GLA mRNAs and the
39-region of the poliovirus IRES of Ren-PV-IRES transcripts.
To clarify the importance of the di-nucleotide sequence around
the cleavage site for the nsp1-induced RNA cleavage, we
examined the nsp1-induced endonucleolytic RNA cleavage sites
in a mutated GLA mRNA mt 1, which had the same predicted
RNA secondary structure as that of GLA mRNA at the 59
noncoding region and carried two nucleotide substitutions from
C17A18 to G17U18 at the major cleavage site and another two
nucleotide substitutions from U25G26 to A25C26; the latter two
nucleotide substitutions were necessary to retain the predicted
RNA secondary structure (refer to Figure 8C). Primer extension
analysis showed that nsp1 induced a major endonucleolytic RNA
cleavage at nucleotides 18 and 26 of GLA mt 1(Figure 8A),
supporting the notion that there is little or no requirement for a
specific nucleotide sequence at the RNA cleavage site for nsp1-
induced RNA cleavage. Unlike GLA mRNA, GLA mRNA mt 1
had an additional cleavage site at nucleotide 9 (Figure 8A).
Incubation of nsp1 with GLA mRNA mt 2 (carrying only a
C17A18 to G17U18 change at the major cleavage site and
having an altered predicted RNA secondary structure) in RRL
resulted in major and minor cleavages at nucleotides 9 and 16,
respectively (Figure 8B). These data led us to conclude that the
nsp1-induced endonucleolytic RNA cleavage of the template
mRNAs displayed no apparent nucleotide preference at the
RNA cleavage site, while altering the RNA secondary structure
affected the pattern of cleavage.
by enumerated arrows and major RNA modification sites are marked with asterisks. IVT RNA, primer extension analysis of in vitro-transcribed RNAs
that were not incubated in RRL; AUG, translation initiation AUG (AUG-834) of EMCV IRES. (C, D) RNA modification sites in Ren-EMCV-FF (C) and Ren-
PV-FF (D). The structural domain L of the EMCV IRES (C) [39] in Ren-EMCV-FF and the poliovirus IRES stem-loop IV (D) [75] in Ren-PV-FF are also shown.
Arrows indicate RNA modification sites and asterisks denote the main ones. The underlined AUG triplet is equivalent to the translation initiation
codon AUG-834 in the EMCV genome (C) and the boxed AUG triplet is equivalent to the AUG-586 of the poliovirus genome. AUG-586 of the
poliovirus is mapped ,150 nt upstream of the authentic viral translation initiation codon.
doi:10.1371/journal.ppat.1002433.g003
RNA Cleavage Caused by SARS Coronavirus nsp1
PLoS Pathogens | www.plospathogens.org 6 December 2011 | Volume 7 | Issue 12 | e1002433Figure 4. Characterization of nsp1-induced RNA modification in ALA mRNA. (A) Capped and polyadenylated ALA mRNA was incubated
with GST, nsp1 or nsp1-mt in RRL, and rluc reporter activities were determined by an rluc assay (Promega). At the top is a schematic diagram of ALA
mRNA, in which 59 UTR and the rluc gene are not shown to scale. (B) RNAs were extracted after incubation with GST, nsp1 or nsp1-mt and subjected
to primer extension analysis by using a 59-end labeled primer that binds to ,100 nt downstream of the rluc gene translation initiation codon. Primer
extension products were resolved on 8% polyacrylamide/7M Urea DNA sequencing gels, and premature primer extension termination signals are
shown by enumerated arrows. Main RNA modification products (sites 3 and 4) are marked with asterisks. 59-end, full-length primer extension product;
IVT RNA, primer extension analysis of in vitro-transcribed ALA mRNA that was not incubated in RRL; AUG, translation initiation codon of rluc gene. (C)
RNA modification sites of ALA mRNA. Arrows indicate RNA modification sites with main RNA modification sites marked with asterisks. (D) Predicted
secondary structure of human b-actin 59 UTR. Arrows indicate main RNA modification sites.
doi:10.1371/journal.ppat.1002433.g004
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nsp1-induced endonucleolytic RNA cleavage
Efficient viral gene expression occurs in SCoV-infected cells in
spite of the nsp1-mediated host gene expression suppression [52].
Furthermore, cells infected with SCoV and those infected with
SCoV-mt, a SCoV mutant encoding nsp1-mt, accumulated
similar amounts of SCoV mRNAs [23]. These data led us to
hypothesize that viral mRNAs are resistant to the nsp1-induced
endonucleolytic RNA cleavage. To test this hypothesis, poly(A)
containing intracellular RNAs were purified from SCoV-infected
cells and incubated with GST, nsp1, or nsp1-mt in RRL. The
RNAs were then extracted and subjected to primer extension
analysis by using a 59-end labeled primer that binds to a region
,120 nt from the 59-end of SCoV mRNA 9, the smallest and
most abundant viral mRNA encoding the N protein. Due to the 39
co-terminal nested structure of coronavirus mRNAs, it was
Figure 5. Characterization of nsp1-induced RNA modification in GLA mRNA. (A-D) Experiments similar to those described in Figure 4 were
performed to obtain the results depicted in Figure 5, except that GLA mRNA, instead of ALA mRNA, was used.
doi:10.1371/journal.ppat.1002433.g005
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mRNAs and generate primer extension products from all viral
mRNAs. The expected sizes of the full-length primer extension
products of viral mRNA 1 to mRNA 8 would exceed 300 nt, and
our primer extension conditions were not suitable for precisely
detecting potential nsp1-induced endonucleolytic RNA cleavage
sites in these viral mRNAs. Hence, we examined whether nsp1
induced endonucleolytic RNA cleavage in mRNA 9, for which the
expected length of full-length cDNA product was ,120 nt.
Remarkably, we did not detect primer extension premature
termination signals that were specific for the sample incubated
with nsp1 (Figure 9A). Furthermore, the amount of the full-length
cDNA product of mRNA 9 was similar among these three
samples. These data demonstrated that SCoV mRNA 9 was not
susceptible to nsp1-mediated endonucleolytic RNA cleavage. To
exclude an unlikely possibility that nsp1 exerts modification at the
59-region of SCoV mRNAs in infected cells and cannot further
modify viral mRNAs in RRL, we repeated the experiments by
using mRNAs from cells infected with SCoV-mt. SCoV-mt
encodes nsp1-mt [23] that does not induce modification of non-
viral mRNAs [22,23], and thus host and viral mRNAs in SCoV-
mt-infected cells should not undergo the nsp1-induced endonu-
cleolytic RNA cleavage. If SCoV mRNAs do not undergo the
nsp1-induced endonucleolytic RNA cleavage in infected cells, then
SCoV mRNA 9 and SCoV-mt mRNA 9 should have the same
Figure 6. Characterization of nsp1-induced RNA modification
in rabbit b-globin mRNA. Poly A+ RNA was extracted from
micrococcal nuclease-untreated RRL (Promega) and incubated with
GST, nsp1 or nsp1-mt in micrococcal nuclease-treated RRL. RNA was
extracted and subjected to primer extension analysis with a rabbit b-
globin mRNA-specific primer. Primer extension products were resolved
on 8% polyacrylamide/7M Urea DNA sequencing gels (Top panel).
Premature primer extension termination signals are shown by
enumerated arrows. The main RNA modification product (site 1) is
marked with an asterisk. The 59-end represents a full-length primer
extension product, and the AUG at the top of the figure and underlined
AUG represent the translation initiation codon of b-globin mRNA.
doi:10.1371/journal.ppat.1002433.g006
Figure 7. Characterization of nsp1-induced RNA fragment of
ALA mRNA. Cap-labeled ALA mRNA was incubated with GST, nsp1 or
nsp1-mt in RRL. RNAs were extracted from RRL by using proteinase K
digestion and subsequent phenol/chloroform extraction. A cap-
radiolabeled RNA fragment was detected in a 10% polyacrylamide/7M
Urea DNA sequencing gel electrophoresis. An RNA size marker (ranging
from 10 nt to 100 nt in 10 nt increment) was prepared by using the
Decade Marker system (Applied Biosystems) and applied to the same
gel.
doi:10.1371/journal.ppat.1002433.g007
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the full-length primer extension product of SCoV-mt mRNA 9
and that of SCoV mRNA 9 was the same (Figure 9B). Similar to
the results observed when SCoV mRNA 9 was unaffected in the
presence of nsp1, incubation of SCoV-mt mRNA 9 with nsp1 did
not generate premature primer extension termination signals.
These data excluded the possibility that nsp1 induces endonu-
cleolytic RNA cleavage near the 59-region of SCoV mRNAs in
Figure 8. Identification of RNA modification sites of GLA mutant mRNAs. (A) GLA mutant 1 (GLA mt 1) carrying G17U18 and A25C26
mutations was incubated with GST, nsp1 or nsp1-mt in RRL. RNA was extracted from RRL and subjected to primer extension analysis. Premature
primer extension termination signals are shown by enumerated arrows and asterisks represent RNA modification products in the 59 UTR. 59-end, full-
length primer extension product; AUG, translation initiation codon of GLA mutant 1. (B) Similar experiments were performed by using GLA mutant 2
(GLA mt 2) with G17U18 mutations. (C) The predicted RNA secondary structures and the nsp1-induced RNA modification sites at the 59 UTRs of GLA
mutant 1 (left), GLA mRNA (middle) and GLA mutant 2 (right). Arrowheads show the RNA modification sites. Mutated sites in the mutants and the
corresponding sites of GAL mRNA are boxed.
doi:10.1371/journal.ppat.1002433.g008
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mRNA 9 is resistant to nsp1-mediated endonucleolytic RNA
cleavage. We also performed primer extension analysis of mRNA
3 from SCoV-infected cells by using a primer that binds to a
region about 150 nt from the 59-end of mRNA 3 (Figure 9C). The
nsp1-treated sample showed neither a reduced amount of the full-
length cDNA product nor specific premature primer extension
termination products, demonstrating that nsp1 did not induce
endonucleolytic RNA cleavage in SCoV mRNA 3.
To identify the RNA element(s) in SCoV mRNAs that protects
the viral mRNAs from the nsp1-induced endonucleolytic RNA
cleavage, we prepared five different SCoV mRNA 9-like RNAs
(Figure 10A). m9LN3 RNA has the following elements: a 59-end
cap structure, the authentic 59 UTR of SCoV mRNA 9, carrying
the common 72 nt-long leader sequence found in all SCoV
mRNAs and an additional 8 nt sequence, the N gene ORF, the 39
UTR, and a 20-nt long poly(A) sequence; naturally occurring
SCoV mRNA 9 and m9LN3 are nearly identical in sequence,
except that the coronavirus mRNAs have a longer 39 poly(A) tail
[53]. m9LN lacks the 39 UTR and the 20 nt poly(A) sequence of
m9LN3, while m9N3 lacks the 59-end leader sequence of m9LN3.
In m9Lrluc3, an rluc gene ORF is inserted in the place of the N
gene ORF in m9LN3. In m9Lactin3, the 59 UTR of actin mRNA
is replaced with the 59 UTR of SCoV mRNA 9; in vitro-synthesized
actin mRNA served as a control. These RNAs were incubated
with GST, nsp1 or nsp1-mt in RRL and subjected to primer
extension analysis (Figures 10B-10F). Similar levels of the full-
length primer extension products of expected sizes were detected
in the m9LN3, m9LN, m9Lrluc3, and m9Lactin3 samples
incubated with nsp1, GST or nsp1-mt (Figures 10B, 10C, 10E
and 10F). We also did not detect any premature primer extension
products in the nsp1-incubated samples. In contrast, incubation of
m9N3 RNA with nsp1 resulted in the generation of two major
premature primer extension products and a reduction in the levels
of the full-length primer extension product (Figure 10D). As
expected, nsp1 induced the endonucleolytic RNA cleavage in actin
mRNA (Figure S3). These data showed that the presence of the
leader sequence protected the viral mRNAs from the nsp1-
induced endonucleolytic RNA cleavage.
Next, we tested the importance of the 59-terminal sequence of
the SCoV leader in protecting viral mRNAs from the nsp1-
induced endonucleolytic RNA cleavage. To this end, we generated
two SCoV mRNA 9-derived mutants, SCoV mRNA 9 mt 1 and
SCoV mRNA 9 mt 2. SCoV mRNA 9 mt 1 has an additional G
at the 59-end and SCoV mRNA 9 mt 2 carries a U to G mutation
in the second nucleotide from the 59-end. The 59-end of SCoV
mRNAs start with the sequence ‘‘m
7GpppAUAU- - -’’, while
SCoV mRNA 9 mt 1 and SCoV mRNA 9 mt 2 start with
Figure 9. Susceptibilities of naturally occurring SCoV mRNAs to nsp1-induced RNA modification. (A and C) Poly A+ RNA was extracted
from SCoV-infected cells and incubated with GST, nsp1 or nsp1-mt in RRL. Extracted RNAs were subjected to primer extension analysis by using
primers suitable for detecting RNA modifications in SCoV mRNA 9 (A) or in SCoV mRNA 3 (C). Primer extension products were resolved in 8%
polyacrylamide/7M Urea DNA sequencing gels: 59-end, full-length primer extension product of SCoV mRNA 9 (A) or SCoV mRNA 3 (C). (B) Similar
experiments described in (A) were performed, except that RNAs from SCoV-mt-infected cells were used.
doi:10.1371/journal.ppat.1002433.g009
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7GpppGAUAU- - -’’ and ‘‘m
7GpppAGAU- - -’’, sequences,
respectively (the additional G nucleotide and the mutated second
nucleotide are underlined). A computer-assisted structural analysis
showed that the 59 UTR of SCoV mRNA 9 and the two mutants
had the same RNA secondary structure (Figure 11A) and previous
structural probing analysis confirmed the existence of three stem-
loops within the leader sequence [54]. Nsp1 induced an
endonucleolytic RNA cleavage in both mutants (Figures 11B
and 11C), demonstrating the importance of an accurate and
authentic 59-terminal sequence of the SCoV leader in the
protection of RNAs from the nsp1-induced endonucleolytic
RNA cleavage.
To determine if nsp1 suppresses the translation of viral mRNAs,
poly(A) containing RNAs were extracted from SCoV-infected or
Figure 10. Susceptibilities of SCoV-like mRNAs to nsp1-induced RNA modification. (A) Schematic diagram showing the structures of SCoV
mRNA 9-like m9LN3, m9LN, m9N3 and m9Lrluc3 RNAs. N, N ORF; rluc, rluc gene. (B, C) In vitro-synthesized m9LN3 RNA and m9LN RNA were
independently incubated with GST, nsp1 or nsp1-mt in RRL. RNAs were extracted and subjected to primer extension analysis by using the same
primer described in Figure 9A. 59-end, full-length primer extension product. (D-F) The experiment was carried out using the same methods as in C,
except that the following combinations of RNA and primer were used: (D) m9N3 RNA and a primer that binds ,76 nt downstream of N gene
translation initiation codon; (E) m9Lrluc3 RNA and a primer that binds ,100 nt downstream of the rluc gene translation initiation codon; and (F)
m9Lactin3 RNA template and a primer that binds ,1 nt downstream of the b-actin gene translation initiation codon.
doi:10.1371/journal.ppat.1002433.g010
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presence of nsp1, nsp1-mt, or GST. GLA mRNA served as a control.
As shown in Figure S4A, the synthesis of the major viral protein, N,
was substantially reduced in the presence of nsp1, but not GST or
nsp1-mt, suggesting that nsp1 suppressed the translation of viral
mRNAs in RRL. We could not examine the effect of nsp1 on
translation of viral mRNAs in HeLa S10 extracts using a similar
radiolabeling assay due to the relatively lower translational activity of
HeLa S10 extracts compared to RRL (data not shown). Instead, we
used a reporter assay to show that nsp1 suppressed the translation of
the SCoV mRNA 9-like RNA, m9Lrluc3 RNA (Figure 10A), in the
HeLa S10 extract (Figure S4B). These data showed that nsp1 did not
induce endonucleolytic RNA cleavage in viral mRNAs but was able
to suppress the translation of viral mRNAs in vitro.
Figure 11. Susceptibilities of SCoV mRNA 9 mutants to nsp1-induced RNA modification. (A) Predicted secondary structure of the 59 UTR
of SCoV mRNA 9. Underlined AUG represents the translation initiation codon. (B, C) In vitro-synthesized SCoV mRNA 9 mt 1 and SCoV mRNA 9 mt 2
RNAs were independently incubated with GST, nsp1 or nsp1-mt in RRL. RNAs were extracted and subjected to primer extension analysis by using the
same primer described in Figure 9A. 59-end, full-length primer extension product. Arrows indicate premature primer extension products.
doi:10.1371/journal.ppat.1002433.g011
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The present study was aimed at identifying the nature of the
nsp1-induced host mRNA modification, exploring the basis of the
RNA modification site selection, and further understanding
template-dependent, nsp1-induced RNA modification by exam-
ining several different RNA templates, including SCoV mRNAs
and their derivatives.
SCoV nsp1-mediated RNA modification
Nsp1 induced an endonucleolytic RNA cleavage within the
IRES region of different dicistronic RNAs containing a picorna-
virus type I IRES or type II IRES [22] (Figure 2 and Figure S1).
Incubation of cap-labeled ALA mRNA with nsp1 in RRL resulted
in the generation of a cap-labeled RNA fragment 29 nt in length
(Figure 7), demonstrating that nsp1 induced an endonucleolytic
RNA cleavage in the ALA mRNA. Thus, the nature of the nsp1-
mediated RNA modification is endonucleolytic RNA cleavage.
This conclusion leads to the question as to the identity of the
enzyme responsible for the endonucleolytic RNA cleavage. Based
on the data that SCoV nsp1 has no similarities in its primary
amino acid sequence or protein structure with any known host
proteins, including RNases [55], and that binding of nsp1 to 40S
ribosomal subunits is required for the nsp1-induced endonucleo-
lytic RNA cleavage [22], we hypothesize that nsp1 is not an
RNase, but uses a host RNase to induce endonucleolytic cleavage
of template mRNAs that interact with 40S ribosomes. Several host
endonucleases are involved in the mRNA surveillance pathways to
detect stalls in translation and are known to exert their function in
association with stalled ribosomes. The host cell RNase, SMG6,
has been shown to play a central role in nonsense-mediated
mRNA decay by inducing an endonucleolytic RNA cleavage in
ribosome-associated host mRNAs containing a pre-mature
termination codon [56]. The no-go mRNA decay pathway detects
stalled ribosomes on mRNAs during translation elongation, and
the yeast dom34/Hbs1 complex is involved in the endonucleolytic
cleavage of mRNAs near the stalled site [57,58]. The archaeal
homolog of the yeast Dom34, Pelota, also exhibits an endonucle-
ase activity [59]. The exosome is involved in the decay of nonstop
mRNAs that lack a stop codon [60], and one of the subunits of the
core eukaryotic exosome has endonuclease activity [61-63]. It is
conceivable that nsp1, in association with ribosomes, uses one of
the host endonucleases involved in mRNA surveillance pathways
to induce RNA cleavage.
We identified the nsp1-induced RNA cleavage sites of several
mRNAs. For Ren-EMCV-FF and Ren-PV-FF, RNA cleavage
mainly occurred near the 39-end of the IRES elements, where the
40S ribosome is recruited (Figures 2 and 3). Many nsp1-induced
cleavage sites in capped mRNAs were mapped within 30 nt of the
59 UTR (Figures 4, 5 and 6), and the ribosome footprint on an
mRNA is about 28 nt in length [64,65]. Thus the cleavage sites of
template mRNAs were either in or proximal to the initial ribosome
binding sites. From these data, we speculate that nsp1-induced
RNA cleavage occurs as soon as a complex of nsp1, 40S ribosome,
and translation initiation factors that bind to 40S ribosomes, e.g.,
eIF1, eIF1A, ternary complex, and eIF3 (we refer to this complex
as the nsp1-40S complex) loads onto mRNA templates.
Gel electrophoresis of
32P cap-labeled ALA mRNA that had
been incubated with nsp1 showed a discrete ,29 nt
32P cap-
labeled RNA fragment (Figure 7). Similarly, primer extension
analysis of ALA mRNA that was incubated with nsp1 also showed
a major premature termination site that corresponded to
nucleotide 29 (site 3) (Figure 4B). Hence, two different experi-
mental approaches convincingly demonstrated that the 29 nt-long
RNA fragment was generated by nsp1-induced endonucleolytic
RNA cleavage. Furthermore, the results of experiments using
primer extension analysis of ALA mRNA (Figure 4) and gel
electrophoresis analysis of cap-labeled ALA mRNA that under-
went nsp1-induced RNA cleavage (Figure 7) led us to speculate
that upon loading of the nsp1-40S complex onto ALA mRNA, an
initial endonucleolytic RNA cleavage occurred at site 3 in ALA
mRNA and the ALA mRNA transcripts that had undergone the
initial RNA cleavage at site 3 were subjected to a second cleavage
at site 4. RNA secondary structure modeling placed these sites in
the vicinity of a stem-loop structure within the 59 UTR (Figure 4D),
which may imply that an RNase carrying out the initial RNA
cleavage at site 3 could easily access site 4 and perform an
additional RNA cleavage. However, the possibility of a host
exonuclease further processing the endonucleolytically cleaved
ALA mRNA at site 3 resulting in the generation of the primer
extension termination site 4 cannot be excluded. Interestingly, the
nsp1-induced RNA cleavage occurred between various dinucleo-
tide sequences (Figures 3, 4, 5, 6 and 8), implying that the enzyme
exerting endonucleolytic RNA cleavage exhibited little nucleotide
preference.
Template-dependent RNA cleavage of non-SCoV RNA
induced by nsp1
Our previous and present studies showed that the nsp1-induced
endonucleolytic RNA cleavage is template dependent. Nsp1
induced RNA cleavage within the 59 UTR of capped mRNAs
and within the picornavirus type I and type II IRES elements,
while IRESes of HCV, CSFV, and CrPV were resistant to nsp1-
induced RNA cleavage. There are differences in the requirement
for translation initiation factors and mechanism of translation
initiation among capped cellular mRNAs and mRNAs harboring
different IRES elements. For cap-dependent translation initiation
of host mRNAs, the 43S pre-initiation complex loads onto the 59-
region of mRNA through its interaction with the eIF4F, which
binds to the 59-end of mRNA and is formed by cap-binding eIF4E,
eIF4A and eIF4G [30,31]. Translation mediated by picornavirus
type I and type II IRESes is independent of the cap-binding
eIF4E, and it has been suggested that IRES-bound eIF4G and
eIF4A recruit the 43S ribosome complex to viral mRNAs [37]. In
contrast, HCV IRES-mediated translation starts by direct loading
of the 40S ribosome onto the HCV IRES [30,31] independent of
any translation initiation factors. This is followed by the joining of
eIF3 and the ternary complex to the HCV IRES-40S ribosome
complex; it is believed that CSFV IRES-mediated translation
initiation uses a similar mechanism [30,31]. Only the 40S and 60S
ribosomes, but not any translation initiation factors, are needed for
translation initiation for the CrPV IRES [30].
Due to differences in the mechanism of translation initiation
between capped cellular mRNAs and mRNAs with IRESes,
several models are conceivable to explain the template-dependent
nature of the nsp1-induced endonucleolytic RNA cleavage. One
model proposes that eIF4A and eIF4G are required for nsp1-
induced RNA cleavage. Namely, eIF4A and/or eIF4G when
associated with mRNA templates may bind nsp1, which then
induces activation of a putative RNase to carry out the RNA
cleavage, and hence the absence of complex formation of HCV,
CSFV or CrPV IRESes with eIF4A and eIF4G prevents the nsp1-
induced RNA cleavage. Another model postulates that the nature
of the complex between nsp1-40S ribosome and the IRESes of
HCV, CSFV and CrPV and the resulting interface between the
RNA and the 40S ribosome is such that it prevents the putative
RNase from accessing and cleaving these IRESes. The third model
proposes that binding of nsp1 to the 40S ribosome may induce a
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HCV, CSFV or CrPV IRESes may not be able to interact with the
40S-nsp1 complex. Thus, these latter mRNAs would not be in
close proximity to the RNase activity induced by the formation of
the nsp1-40S ribosome complex.
Resistance of SCoV mRNAs from nsp1-induced RNA
cleavage
The data that SCoV mRNA 3 and mRNA 9 were not
susceptible to nsp1-mediated endonucleolytic RNA cleavage in
RRL, along with the report that nsp1 did not suppress viral
mRNA accumulation in infected cells [23], strongly suggest that
SCoV mRNAs are resistant to nsp1-induced RNA cleavage in
infected cells. In vitro-synthesized SCoV-like mRNAs containing
the SCoV leader sequence were resistant to nsp1-induced RNA
cleavage, while SCoV-like mRNA lacking the leader sequence was
susceptible to the nsp1-induced RNA cleavage (Figures 9 and 10).
Furthermore, the N gene ORF was dispensable for the resistance
of virus-like mRNAs to nsp1-induced RNA cleavage (Figure 10),
ruling out the possibility that N protein synthesized from SCoV
mRNA 9 in RRL might have acted in trans to prevent the RNA
cleavage. Thus, it was the leader sequence that protected viral and
virus-like mRNAs from the nsp1-induced RNA cleavage.
Several mechanisms are conceivable as to how SCoV mRNAs
escaped from the nsp1-induced endonucleolytic RNA cleavage.
One is that the nsp1-40S complex loads onto SCoV mRNAs in
such a way that the putative RNase that carries out the RNA
cleavage cannot interact with SCoV mRNAs. Because nsp1
induced an RNA cleavage at the very 59-end of SCoV mRNA
9 mt 1, carrying an extra G residue at the 59-end of the transcripts,
and SCoV mRNA 9 mt 2, carrying a U to G substitution at the
second nucleotide position from the 59-end, (Figure 11), the 59-
terminal region of the SCoV leader sequence may play a role in
preventing the putative RNase from associating with the viral
mRNAs. Alternatively, the binding of nsp1 to 40S ribosomes may
induce structural alterations of the 40S ribosome such that
interaction between nsp1-40S complex and SCoV mRNAs does
not occur, and hence the putative RNase that carries out the nsp1-
induced endonucleolytic RNA cleavage cannot gain access to the
SCoV mRNAs. Like typical host mRNAs, SCoV mRNAs have a
59 cap structure [6,7,52] and a 39-end poly(A) tract. Also,
preventing the interaction between eIF4E and eIF4G that inhibits
cap-dependent translation also blocked coronavirus replication
[66]; therefore, the SCoV mRNAs probably undergo cap-
dependent translation. Accordingly, it is also possible that SCoV
mRNAs and IRESes of HCV, CSFV or CrPV use different
strategies to escape from the nsp1-induced RNA cleavage. For
example, the leader sequence of SCoV mRNAs could recruit a
host protein(s) to protect the viral mRNAs from RNA cleavage.
Although SCoV mRNAs are resistant to nsp1-induced endonu-
cleolytic RNA cleavage, translation of SCoV mRNAs and a
reporter mRNA carrying the 59 and 39 UTRs of SCoV mRNA
was suppressed in the presence of nsp1 (Figure S4). These data
were not surprising, because nsp1 inactivates the translation
functions of 40S ribosomes [22]. Although the stoichiometry
between nsp1 and 40S ribosomes in SCoV-infected cells is
unknown, the abundance of 40S ribosomal subunits most likely
exceeds that of nsp1 in infected cells. SCoV mRNAs may be
dissociated easily from the nsp1-40S complex or may not interact
at all with the nsp1-40S complex and efficiently use the nsp1-free
40S ribosomes for their translation. In addition, there may be a
mechanism whereby nsp1-40S ribosomes are excluded from sub-
cellular locations where efficient viral translation takes place in
infected cells to reduce the possibility that viral mRNAs interact
with the nsp1-40S ribosome complex.
Materials and Methods
Preparation of poly A+ mRNAs from SCoV-infected cells
and rabbit reticulocyte lysate
Vero E6 cells were infected with the Urbani strain SCoV or
SCoV-mt [23] at a multiplicity of infection of 1. At 15 h post-
infection, intracellular RNAs were extracted by using TRIzol
reagent (Invitrogen). Total RNA was obtained from nuclease-
untreated rabbit reticulocyte lysates (Promega) by proteinase K
digestion, phenol/chloroform extraction and ethanol precipita-
tion. In both samples, poly A+ mRNAs were further prepared by
using Oligotex poly A
+ RNA purification Kit (Qiagen).
Plasmid construction
Replacing the rluc gene of pRL-SV40 (Promega) with the PCR
product containing a T7 promoter sequence, 59 UTR of human b-
actin mRNA, rluc gene and a 50-nt-long poly(A) tail resulted in
pALA-SV40 encoding ALA mRNA. A similar method was used to
generate pGLA-SV40 encoding GLA mRNA, except that the 59
UTR of human b-actin mRNA in pALA-SV40 was replaced by
the 59 UTR of rabbit b-globin mRNA. By using pGLA-SV40 as a
template, we employed a QuikChange site-directed Mutagenesis
Kit (Stratagene) to generate plasmids encoding GLA mRNA
mutants. A reporter plasmid, pRL-HL, carrying in the following
order: a CMV promoter, T7 promoter, rluc ORF, HCV IRES
and fluc ORF, was described previously [22,67]. The plasmids
pRL-TMEV-FL, pRL-PV IRES-FL, pRL-CVB3 IRES-FL, pRL-
HRV2 IRES-FL and pRL-CSFV IRES-FL were constructed by
replacing the HCV IRES region of plasmid pRL-HL with that of
following viruses and the nucleotide sequences of the viral genome
from which they were derived: the DA strain of TMEV IRES, nt
395-1068; type 1 poliovirus IRES, nt 108-745; coxsackievirus B3
IRES, 100-741; human rhinovirus 2 IRES, nt 101-610; and
classical swine fever virus IRES, nt 1-441. The RT-PCR product
encoding rabbit b-globin mRNA was cloned into cloning vector
pSMART (Lucigen), yielding pSG. The RT-PCR product of full-
length SCoV mRNA 9 was cloned into pcDNA3.1 myc/His
(Invitrogen), generating pcDm9LN3. The PCR product carrying a
T7 class II W2.5 promoter, human b-actin mRNA (amplified from
HEK 293 cells) and a 20-nt-long poly(A) tail was cloned into the
vector pSMART, yielding pSA. The plasmid, pSm9Lactin3,
encoding human b-actin mRNA carrying the 59 UTR of SCoV
mRNA 9, was generated by replacing the 59 UTR of human b-
actin mRNA in pSA with the 59 UTR of SCoV mRNA 9.
Sequence analyses of the plasmids confirmed the presence of the
expected sequence.
In vitro RNA transcription
Transcription of dicistronic RNA transcripts was described
previously [22,67]. Capped and polyadenylated RNA transcripts
were synthesized from linearized plasmids in vitro by using the
mMESSAGE mMACHINE T7 kit or T7 Ultra kit (Applied
Biosystems) according to the manufacturer9s protocol. Synthesis of
SCoV mRNA 9 was performed as previously described [68,69].
The PCR product of full-length SCoV mRNA 9 was generated by
using pcDm9LN3 as a template and primers T7 phi2.5-59SARS,
59-CGGAGTAATACGACTCACTATTATATTAGGTTTTT-
ACCTACCC-OH, and SARS 39 UTR primer, 59-TTT-
TTTTTTTTTTTTTTTTTGTCATTCTCCTAAGAAG-OH;
to ensure that the 59-proximal sequence of the in vitro synthesized
RNA was identical to that of authentic SCoV mRNA 9, the T7
RNA Cleavage Caused by SARS Coronavirus nsp1
PLoS Pathogens | www.plospathogens.org 15 December 2011 | Volume 7 | Issue 12 | e1002433class II W2.5 promoter (underlined sequence) was used to initiate
transcription by ATP, instead of GTP [70]. To serve as a template
for the synthesis of m9N3 RNA, SCoV mRNA 9 mt 1 RNA, and
SCoV mRNA 9 mt 2 RNA, a PCR product was generated using
the following forward primers with the SARS 39 UTR primer,
respectively: 59-AATTAATACGACTCACTATAG AACAAAT-
TAAAATGTCTGATA ATGG-OH (T7 promoter sequence
underlined); 59-AATTAATACGACTCACTATAG ATAT-
TAGGTTTTTACCTACC-OH (T7 promoter sequence under-
lined); and 59-CGGGATCCGAG TAATACGACTCACTATT
AGATTAGGTTTTTACCTACCC-OH (the T7 class II W2.5
promoter sequence underlined). The amplicon, purified on an
agarose gel, served as a template for the synthesis of uncapped
SCoV mRNA 9 using the MEGAscript T7 kit (Applied
Biosystems). The in vitro synthesized SCoV mRNA 9 was purified
with the RNeasy mini kit (Qiagen), capped with vaccinia virus
capping enzyme using the ScriptCap m
7G Capping System
(Epicentre Biotechnology) and further purified with the RNeasy
mini kit (Qiagen). Similar procedures were used for the generation
of m9LN and m9LrLuc3 RNAs, except that the PCR products, as
shown in Figure 10, serve as templates for RNA synthesis, and a
reverse primer that binds to the 39-end of N gene was used to
generate the PCR for transcription of m9LN RNA.
In vitro translation
In vitro translation was performed using the Retic Lysate IVT kit
(Applied Biosystems). RRL was initially incubated with 1 mg GST
protein, nsp1 protein or nsp1-mt protein purified from E. coli at
4
oC for 10 min [22]. Then, 0.25 mg mRNA and an amino acid
mixture (Promega, to a final concentration of 1 mM) were added;
the molar ratio of nsp1 to mRNA was approximately 200:1.
Samples were incubated at 30uC for 10 min. In some experiments,
HeLa S10 extract was added to RRL at a final concentration of
20% [71], as indicated, and translation was performed at 30uC for
10 min. After incubation, the samples were incubated with
proteinase K, and the extracted RNAs were subjected to Northern
blot or primer extension analyses. In some experiments, luc assays
were performed by adding 5 ml translation product in 100 ml
Renilla Luciferase Lysis Buffer (Promega). Luminescence was
measured by using a Renilla luciferase assay system (Promega).
Primer extension analysis
After incubation of RNA samples with the 59-end
32P labeled
primers (40,000 c.p.m), primer extension was performed by using
the Primer Extension System (Promega) according to the manufac-
turer’s protocol. The RNAs, primer sequence, and primer-binding
site and conditions are as follows: GLA and ALA mRNAs, 59-
TTTTTCTGAATCATAATAATTAA-39, ,100 nt downstream
of rluc translation initiation codon, incubation at 42uC for 1 h and
subsequent incubation at room temperature for 10 min; Ren-
EMCV-FF, 59-AGCAATTGTTCCAGGAACCAGGG, ,100 nt
downstream of fluc translation initiation codon, incubation at 55uC
for 1 h and subsequent incubation at room temperature for 10 min;
Ren-PV-FF, 59-GGGCCTTTCTTTATGTTTTTGGCG, ,6n t
downstream of AUG translation initiation codon of fluc gene,
incubation at 55uC for 1 h and subsequent incubation at room
temperature for 10 min; SCoV mRNA 9, m9LN3, and m9LN, 59-
GGGTCCACCAAATGTAATGC-39, ,44 nt downstream of N
gene translation initiation codon, incubation at 50uC for 1 h and
subsequent incubation at room temperature for 10 min; SCoV
mRNA 3, 59-TGTAGCATGAACAGTACTTGC-39, ,75 nt
downstream of 3a gene translation initiation codon, incubation at
50uC for 1 h and subsequent incubation at room temperature for
10 min; m9LrLuc3,59- TTTTTCTGAATCATAATAATTAA-39,
,100 nt downstream of rluc translation initiation codon, incuba-
tion at 42uC for 1 h and subsequent incubation at room
temperature for 10 min; and m9N3, 59-GTCCTCCATTCTGGT-
TATTGTC-39, ,76 nt downstream of N gene translation
initiation codon, incubation at 50uC for 1 h and subsequent
incubation at room temperature for 10 min; m9Lactin3 and actin,
59- AGCGCGGCGATATCATCATC-39, ,1 nt downstream of
the AUG translation initiation codon of b-actin gene, incubation at
55uC for 1 h and subsequent incubation at room temperature for
10 min. AMV reverse transcriptase was used for primer extension.
After ethanol precipitation, the primer extension products were
resolved in 8% polyacrylamide/7M Urea DNA sequencing gels.
Analysis of the nsp1-induced cleavage product of cap-
labeled ALA mRNA and preparation of RNA size markers
Uncapped and polyadenylated ALA mRNA was prepared by
using the MEGAscript in vitro transcription kit (Applied Biosys-
tems). Cap labeling was performed by incubation of 30 mgo f
uncapped RNA with vaccinia virus capping enzyme (ScriptCap
m
7G capping system) in the presence of a-
32P GTP (3,000 Ci/
mmole, MP) at 37uC for 1 h. Cap-radiolabeled ALA mRNA was
purified with the RNeasy mini kit and 0.75 mg RNA (approxi-
mately 100,000 cpm/mg) was used for in vitro translation in RRL.
Then the sample was incubated with proteinase K, and RNA was
extracted by phenol/chloroform.
The RNA size marker (ranging from 10 nt to 150 nt) was
prepared with the Decade Marker system (Applied Biosystems)
according to the manufacturer’s instruction with modifications.
Full-length Decade Marker RNA (0.5 mg) of 150 nt in length was
cap labeled with vaccinia virus capping enzyme in the presence of
a-
32P GTP (3,000 Ci/mmole, MP). After ethanol precipitation,
the cap-labeled marker RNA was dissolved in a solution
containing 8 mlH 2O, 1 ml 10X kinase buffer (Decade Marker
system, Applied Biosystems) and 1 ml 10X cleavage reagent
(Decade Marker system, Applied Biosystems). The full-length
RNA marker was cleaved into an RNA ladder by incubation at
room temperature for 5 min. The produced RNA ladder
contained a set of cap-labeled RNA molecular weight markers of
150, 100, 90, 80, 70, 60, 50, 40, 30, 20 and 10 nt in length. An
equal volume of 2x proteinase K digestion buffer was added to the
prepared Decade Marker RNA ladder to adjust the salt
concentration to a level similar to that of RNA samples extracted
from RRL. The RNA samples were analyzed on 10% polyacryl-
amide/7M Urea DNA sequencing gels.
Supporting Information
Figure S1 Susceptibilities of Ren-CVB-FF and Ren-
HRV2-FF to nsp1-mediated RNA cleavage. (A) Schematic
diagram of the structures of full- length dicistronic RNA
transcripts (Full length), RNA 1 containing the 59 rluc gene and
intercistronic IRES sequence and RNA 2 containing only the 59
rluc gene. (B and C) Ren-CVB-FF (B) and Ren-HRV2-FF (C)
were independently incubated with GST, nsp1, or nsp1-mt or
without any protein (mock) in RRL+HeLa at 30uC for 10 min.
RNA samples were extracted and analyzed by Northern blotting
using an 59 rluc probe (left panel) and 39 fluc probe (right panel).
Marker represents a mixture of in vitro-transcribed full length RNA
transcripts, RNA 1 and RNA 2.
(TIF)
Figure S2 Susceptibilities of discistonic RNA tran-
scripts carrying different IRESes to nsp1-mediated
RNA cleavage in cells. Plasmids pCAGGS-CAT encoding
the CAT gene, pCAGGS-nsp1 encoding nsp1 and pCAGGS-
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CMV promoter-driven dicistronic reporter plasmids encoding the
59 rluc gene, IRES and 39 fluc gene in HEK293 cells. The IRESes
included in the RNA expression plasmid were: TMEV IRES (A),
poliovirus IRES (B), HCV IRES (C) or CSFV IRES (D). After
24 hr, total RNA was extracted from the cells by using Trizol
reagent. Samples were treated with DNase I and RNAs were
purified with RNeasy (Qiagen). The RNAs were subjected to
Northern blot analysis using an rluc probe.
(TIF)
Figure S3 Susceptibility of actin mRNA to nsp1-induced
RNA modification. In vitro-synthesized actin mRNA was
incubated with GST, nsp1 or nsp1-mt in RRL. RNAs were
extracted and subjected to primer extension analysis by using the
same primer described in Figure 10F. 59-end, full-length primer
extension product. Arrows indicate premature primer extension
products.
(TIF)
Figure S4 Effect of nsp1 on translation of SCoV mRNA
in RRL and SCoV-like mRNA encoding a reporter
protein in HeLa S10 extract. (A) Intracellular polyA+ RNAs
obtained from SCoV-infected Vero E6 cells (SCoV-infected) were
subjected to an in vitro translation reaction in the presence of
35S-
methionine along with GST, nsp1 or nsp1-mt in RRL (left panel).
As a control, intracellular poly A+ RNA from mock-infected Vero
E6 cells was subjected to in vitro translation in the presence of GST
(Mock). A similar in vitro translation assay was performed using in
vitro-transcribed capped GLA mRNA (right panel). The radiola-
beled proteins were analyzed by SDS-PAGE and autoradiogra-
phy. SCoV major structural protein (N protein) and rluc protein
are indicated by arrows. (B) In vitro synthesized m9Lrluc3, a SCoV
mRNA 9-like reporter mRNA carrying an rluc gene in the place of
N gene ORF (Figure 10), was subjected to an in vitro translation
assay in HeLa S10 extract in the presence of GST (GST) or nsp1
proteins (nsp1). After 1.5 h incubation, the rluc activity was
measured and represented as the average of three independent
experiments (+/- SD).
(TIF)
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